Prospera Financial Services Inc Eli Lilly & CO Transaction History

Prospera Financial Services Inc

$3.82 Billion
Q3 2024

A detailed history of Prospera Financial Services Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Prospera Financial Services Inc holds 24,629 shares of LLY stock, worth $19.6 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

24,629

Previous 22,987 7.14%

Holding current value

$19.6 Million

Previous $20.8 Million 4.84%

% of portfolio

0.57%

Previous 0.59%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$772.14 - $960.02 $1.27 Million - $1.58 Million	1,642 Added 7.14%	24,629 $21.8 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $7.6 Million - $9.53 Million	10,482 Added 83.82%	22,987 $20.8 Million
Q1 2024 Aug 13, 2024	SELL	$592.2 - $792.28 $1.84 Million - $2.46 Million	-3,100 Reduced 13.49%	19,887 $15.5 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $370,784 - $437,105	706 Added 5.98%	12,505 $7.29 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $309,506 - $426,701	712 Added 6.42%	11,799 $6.34 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $228,682 - $305,774	652 Added 6.25%	11,087 $5.2 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $446,064 - $523,881	1,436 Added 15.96%	10,435 $3.58 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $1.31 Million - $1.53 Million	-4,076 Reduced 31.17%	8,999 $3.29 Million
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $466,956 - $532,145	1,575 Added 13.7%	13,075 $4.23 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $743,930 - $873,483	2,669 Added 30.22%	11,500 $3.73 Million
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $16,897 - $20,999	72 Added 0.82%	8,831 $2.53 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $142,779 - $177,190	635 Added 7.82%	8,759 $2.42 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $348,576 - $428,972	1,573 Added 24.01%	8,124 $1.88 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $7,763 - $10,042	43 Added 0.66%	6,551 $1.5 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $120,939 - $156,561	-736 Reduced 10.16%	6,508 $1.22 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $373,115 - $493,721	2,860 Added 65.24%	7,244 $1.22 Million
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $3.38 Million - $3.91 Million	-23,136 Reduced 84.07%	4,384 $649,000
Q2 2020 Aug 07, 2020	SELL	$136.42 - $164.18 $1.02 Million - $1.23 Million	-7,472 Reduced 21.35%	27,520 $4.52 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $3.53 Million - $4.37 Million	29,671 Added 557.62%	34,992 $4.85 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $16,038 - $19,864	150 Added 2.9%	5,321 $699,000
Q3 2019 Oct 22, 2019	SELL	$106.79 - $116.16 $4,378 - $4,762	-41 Reduced 0.79%	5,171 $578,000
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $166,517 - $194,367	-1,503 Reduced 28.72%	3,731 $430,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $164,079 - $191,522	1,481 Added 39.69%	5,212 $583,000
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $167,298 - $196,923	1,503 Added 40.28%	5,234 $667,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $189,349 - $212,128	-1,788 Reduced 32.4%	3,731 $430,000
Q3 2018 Oct 25, 2018	SELL	$85.86 - $107.31 $18,459 - $23,071	-215 Reduced 3.75%	5,519 $569,000
Q2 2018 Jul 18, 2018	SELL	$75.7 - $86.88 $40,499 - $46,480	-535 Reduced 8.53%	5,734 $493,000
Q1 2018 Apr 12, 2018	BUY	$74.21 - $87.6 $128,086 - $151,197	1,726 Added 37.99%	6,269 $490,000
Q4 2017 Jan 24, 2018	SELL	$81.94 - $87.89 $408,552 - $438,219	-4,986 Reduced 52.32%	4,543 $387,000
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $734,400 - $815,110	9,529	9,529 $826,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Eli Lilly & CO Transaction History